Squarepoint’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,859
Closed -$212K 2742
2024
Q4
$212K Buy
+12,859
New +$212K ﹤0.01% 2360
2024
Q3
Sell
-21,648
Closed -$548K 2519
2024
Q2
$548K Sell
21,648
-30,809
-59% -$780K ﹤0.01% 1680
2024
Q1
$1.33M Sell
52,457
-6,098
-10% -$155K ﹤0.01% 1201
2023
Q4
$1.33M Buy
58,555
+38,835
+197% +$880K ﹤0.01% 1218
2023
Q3
$367K Buy
+19,720
New +$367K ﹤0.01% 1806
2022
Q2
Sell
-19,288
Closed -$484K 2104
2022
Q1
$484K Buy
+19,288
New +$484K ﹤0.01% 1511
2021
Q4
Sell
-4,921
Closed -$209K 2516
2021
Q3
$209K Sell
4,921
-7,015
-59% -$298K ﹤0.01% 1804
2021
Q2
$517K Buy
11,936
+6,074
+104% +$263K ﹤0.01% 1585
2021
Q1
$239K Buy
5,862
+489
+9% +$19.9K ﹤0.01% 2047
2020
Q4
$243K Buy
+5,373
New +$243K ﹤0.01% 2007
2020
Q1
Sell
-28,153
Closed -$1.46M 1825
2019
Q4
$1.46M Buy
28,153
+13,545
+93% +$702K 0.01% 1063
2019
Q3
$802K Buy
+14,608
New +$802K 0.01% 1336
2019
Q2
Sell
-9,800
Closed -$296K 2272
2019
Q1
$296K Sell
9,800
-11,763
-55% -$355K ﹤0.01% 1733
2018
Q4
$725K Buy
+21,563
New +$725K 0.01% 1045
2018
Q2
Sell
-10,536
Closed -$524K 1730
2018
Q1
$524K Buy
10,536
+4,026
+62% +$200K 0.01% 1071
2017
Q4
$351K Sell
6,510
-527
-7% -$28.4K 0.01% 1398
2017
Q3
$408K Buy
+7,037
New +$408K 0.01% 1035
2016
Q3
Sell
-3,955
Closed -$212K 998
2016
Q2
$212K Buy
+3,955
New +$212K 0.01% 872